Xometry, Inc. $XMTR Shares Bought by Baillie Gifford & Co.

Baillie Gifford & Co. boosted its holdings in shares of Xometry, Inc. (NASDAQ:XMTR) by 1.6% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,306,151 shares of the company’s stock after buying an additional 20,901 shares during the period. Baillie Gifford & Co. owned approximately 2.55% of Xometry worth $77,677,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds also recently added to or reduced their stakes in XMTR. Quantbot Technologies LP acquired a new position in Xometry during the 3rd quarter valued at about $30,000. Westend Capital Management LLC acquired a new position in shares of Xometry in the third quarter valued at about $41,000. GAMMA Investing LLC increased its holdings in shares of Xometry by 26.5% in the fourth quarter. GAMMA Investing LLC now owns 773 shares of the company’s stock valued at $46,000 after purchasing an additional 162 shares during the period. Global Retirement Partners LLC acquired a new position in shares of Xometry in the third quarter valued at about $47,000. Finally, Comerica Bank increased its holdings in shares of Xometry by 17.9% in the third quarter. Comerica Bank now owns 1,140 shares of the company’s stock valued at $62,000 after purchasing an additional 173 shares during the period. 97.31% of the stock is owned by institutional investors and hedge funds.

Insider Transactions at Xometry

In other news, Director Emily Rollins sold 1,000 shares of the company’s stock in a transaction dated Wednesday, April 1st. The stock was sold at an average price of $42.02, for a total value of $42,020.00. Following the sale, the director owned 15,136 shares in the company, valued at $636,014.72. This represents a 6.20% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Katharine Weymouth bought 1,215 shares of the stock in a transaction dated Friday, February 27th. The stock was bought at an average price of $41.15 per share, for a total transaction of $49,997.25. Following the purchase, the director directly owned 3,615 shares of the company’s stock, valued at approximately $148,757.25. The trade was a 50.63% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. Over the last ninety days, insiders have sold 68,090 shares of company stock valued at $3,032,592. 9.66% of the stock is owned by insiders.

Xometry Stock Up 5.4%

Shares of XMTR opened at $42.61 on Tuesday. Xometry, Inc. has a 52 week low of $20.95 and a 52 week high of $73.87. The company has a quick ratio of 3.72, a current ratio of 3.76 and a debt-to-equity ratio of 1.18. The company has a market capitalization of $2.21 billion, a price-to-earnings ratio of -34.93 and a beta of 0.88. The stock’s 50-day moving average price is $46.99 and its 200-day moving average price is $54.20.

Xometry (NASDAQ:XMTR) last issued its earnings results on Tuesday, February 24th. The company reported $0.16 EPS for the quarter, topping analysts’ consensus estimates of $0.12 by $0.04. Xometry had a negative return on equity of 5.49% and a negative net margin of 8.99%.The firm had revenue of $192.40 million for the quarter, compared to the consensus estimate of $183.37 million. During the same quarter in the prior year, the business earned $0.06 earnings per share. The company’s revenue was up 29.5% compared to the same quarter last year. On average, sell-side analysts predict that Xometry, Inc. will post -0.66 EPS for the current year.

Wall Street Analyst Weigh In

A number of brokerages have recently weighed in on XMTR. Weiss Ratings reissued a “sell (e+)” rating on shares of Xometry in a report on Wednesday, January 21st. William Blair reissued an “outperform” rating on shares of Xometry in a report on Tuesday, February 24th. Royal Bank Of Canada cut their price objective on Xometry from $64.00 to $55.00 and set a “sector perform” rating on the stock in a report on Wednesday, February 25th. UBS Group increased their price objective on Xometry from $54.00 to $55.00 and gave the company a “neutral” rating in a report on Wednesday, February 25th. Finally, Wedbush cut their price objective on Xometry from $70.00 to $60.00 and set an “outperform” rating on the stock in a report on Wednesday, February 25th. Five investment analysts have rated the stock with a Buy rating, five have assigned a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, the stock presently has an average rating of “Hold” and an average target price of $62.00.

Xometry Profile

Xometry, Inc (NASDAQ: XMTR) operates a technology-driven marketplace that connects businesses with on-demand manufacturing capacity across a wide array of processes. Through its proprietary Instant Quoting Engine and Xometry Platform, the company streamlines sourcing for CNC machining, 3D printing, sheet metal fabrication, injection molding, urethane casting and other custom manufacturing services. By aggregating a network of thousands of vetted suppliers, Xometry offers rapid lead times, transparent pricing and real-time order tracking to customers in sectors ranging from automotive and aerospace to medical devices and industrial equipment.

Since its founding in 2013 and headquarters in Rockville, Maryland, Xometry has expanded its geographic reach to serve customers in North America, Europe and beyond.